Lipoprotein (a) and Ischaemic Cerebrovascular Disease

Marcovina SM Levine DM Lippi G. Lipoprotein(a): Structure, measurement, and clinical significance. In: Rifai N Warnick R . eds. Laboratory Measurement of Lipids, Lipoproteins, and Apolipoproteins. Washington, DC: AACC Press, 1994: 253–64.

Fortmann SP Marcovina SM . Lipoprotein(a), a clinically elusive lipoprotein particle. Circulation 1997; 95: 295–6.

Markus HS Kapadia R Sherwood RA . Relationship between lipoprotein (a) and both stroke and carotid atheroma. Ann Clin Biochem 1997; 34: 360–5.

Pedro-Botet J Senti M Nogués X Rubiés-Prat J Roqur J D'Olhaberriague L Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke 1992; 23: 1556–62.

Cambillau M Simon A Amar J Giral PH Atger V Segond P Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. Arterioscler Throm 1992; 12: 1346–52.

Lassila R Manninen V. Hypofibrinolysis and increased lipoprotein(a) coincide in stroke. J Lab Clin Med 1995; 125: 301–2.

Kario K Matsuo T Kobayashi H Asada R Matsuo M. “Silent” cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. Arterioscler Thromb Vasc Biol 1996; 16: 734–41.

Hiraga T Shimada M Okubo M Nakanishi K Kobayashi T Murase T. Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions. Atherosclerosis 1996; 122: 29–32.

Choe YH Choi Y Kim JQ . Lipoprotein(a) in Korean children and a history of coronary or cerebral vascular events in their older family members. Ann Clin Biochem 1997; 34: 179–84.

Hong Y Dahlen G Pederson N Heller D McClearn G de Faire U. Potential environmental effects on adult lipoprotein(a) levels: Results from Swedish twins. Atherosclerosis 1995; 117: 295–304.

Bruckert E Davidoff P Grimaldi A Truffert J Giral P Doumith R Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA 1990; 263: 35–6.

Sechi LA Kronenberg F De Carli S Falleti E Zingaro L Catena C Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA 1997; 277: 1689–95.